| |
Read
More
How
Safe is Your
Pain Medication?
The
Role of Inflammation in the
Healing Process
Diet
and Inflammation
The
Importance
of Excercise
How
CircuPrime Resolves
Inflammation
Links
and Suggested Reading
|
|
How
Safe is Your
Pain Medication
By
Kenneth Proefrock,
NMD
Aspirin is,
arguably, the
world's favorite
pain reliever.
It has been
around for at
least 3,500
years as a constituent
of many botanically
based medicines,
and since 1898
as a pure drug.
Despite its
long usage by
humans, we did
not really understand
how it worked
until research
by a scientist
named Vane in
the early 1970's
discovered that
aspirin acted
to inhibit a
cyclo-oxygenase
or “cox” enzyme.
Cox enzymes
are enzymes
that convert
a common fatty
acid found in
the membranes
of your cells,
arachidonic
acid, into certain
eicosanoids.
An eicosanoid
is a compound
that has a 20
carbon chain
backbone and
acts like a “sub-hormone”,
they set the
stage for other
hormones to
work, but eicosanoids
are extremely
short-lived,
most lasting
less than a
few seconds
in the body.
Some of these
eicosanoids
are helpful
in the repair
of your tissues,
and have an
anti-inflammatory,
pain relieving
quality. Many
of these eicosanoids
are proinflammatory
and increase
the perception
of pain in our
nervous systems
while they inhibit
appropriate
healing responses.
Aspirin was
the first cox
inhibitor to
be described,
and now, there
are over 50
distinct cox
inhibitors currently
in use. There
are three different
subtypes of
cox enzymes,
cox 1 is considered
to be the most
beneficial and
is involved
in membrane
repair and immune
function, cox
2 and 3 are
considered to
be more inflammatory.
Aspirin is an
indiscriminant
and, in many
cases, an irreversible
inhibitor of
all three of
the different
classes of cox
enzymes. It
has the most
notable side
effects of inhibiting
repair of the
gastrointestinal
tract and promoting
the formation
of ulcers due
to its effects
in cox 1 inhibition.
One of the most
common accidental
poisonings to
present in the
emergency room
is from over-ingestion
of aspirin.
This continues
to be true especially
for children
less than 5
years old despite
safety packaging
laws. Overdose
is most common
after several
days of a larger
therapeutic
dose, this is
typically a
dosage that
lies within
the safe therapeutic
range for acute
conditions,
just used for
longer than
intended.
Acetaminophen is anything
but a safe and
harmless alternative
to aspirin.
Its toxicity
has been well
documented since
the 1960's,
and there are
currently over
100 over the
counter products
on the market
that contain
acetaminophen.
These include
many products
directed towards
the pediatric
population in
liquid, capsule
and tablet form.
The symptoms
of toxicity
are very different
from those of
aspirin; symptoms
don't usually
develop until
48 hours after
ingestion, and
include liver
failure. Acetaminophen
and ibuprofen
seem to have
a greater affinity
for cox 3 receptors,
but still affect
cox 1 and 2,
the side effects
are similar
to those of
aspirin, decreasing
the ability
of the gastrointestinal
tract to heal
itself, leading
to the formation
of ulcers. Alcohol
ingestion dramatically
increases its
toxic nature.
One of the
biggest challenges
in the field
of drug development
has been to
develop agents
that specifically
inhibit the
inflammatory
cox 2 and 3
enzymes, without
adversely affecting
the beneficial
cox 1 system.
Enter specific
cox 2 enzyme
inhibitors like
Vioxx, Celebrex
and Bextra.
The promise
of these agents
was that they
could specifically
reduce the inflammation
associated with
many pain syndromes,
without the
nasty side effects
and toxicity
associated with
the more broadly
acting cox inhibitors.
The introduction
of theses agents
in the early
1990's was met
with the expectation
that now modern
medicine would
have a viable
answer for the
millions of
people who suffer
from chronic
pain. On Sept.
30, 2004, Vioxx
was the first
of these agents
to be voluntarily
recalled from
the market by
its manufacturer,
Merck Pharmaceuticals,
because of some
very life threatening
side effects.
It turns out
that the entire
model that we
just discussed
and that ushered
in these potential
panaceas was
probably wrong
in several different
aspects. We
now know that
there are even
more cox subtypes
than the three
discussed, we
also know that
inhibiting one
subtype tends
to make the
other major
subtypes proliferate,
increasing their
potentially
harmful effects.
|
|